
Societe Generale has appointed Selina Cheung as head of equity capital markets for Asia Pacific, based in Hong Kong. Cheung will direct the origination and execution of equity and equity‑linked transactions. She arrives from UBS, where she led unified global banking across the region. The hire underscores SocGen’s ambition to grow its ECM franchise and capture more share‑sale mandates in the fast‑moving Asian market.

Public Investment Corp., Africa’s largest money manager, has mutually terminated its Chief Investment Officer Kabelo Rikhotso’s employment after a five‑month suspension triggered by whistleblower misconduct allegations. The firm asserts there is no evidence supporting the claims against Rikhotso and investment‑legal head...

Berkshire Hathaway CEO Greg Abel, in his first shareholder letter, pledged to uphold Warren Buffett’s value‑oriented philosophy and assured investors the conglomerate will thrive beyond Buffett’s tenure. Abel highlighted continuity in long‑term investing, disciplined capital allocation, and the firm’s resilient...

Teleperformance announced Jorge Amar, a former McKinsey partner, as its new chief executive, replacing founder‑CEO Daniel Julien. The leadership shift comes as the French‑listed call‑center giant battles a steep stock decline and mounting pressure from artificial‑intelligence disruption. Amar’s consulting pedigree signals a...

Nvidia projected fiscal Q1 revenue of about $78 billion, topping the average Wall Street forecast of $72.8 billion and approaching the high‑end $80 billion outlook. CEO Jensen Huang highlighted a surge in enterprise adoption of AI agents, indicating that corporate customers are joining...

Aston Martin’s billionaire chairman Lawrence Stroll has struck a financing deal with his own Formula One team to shore up the debt‑laden luxury‑car maker. The arrangement channels cash and technical resources from the F1 operation into Aston Martin, aiming to reduce...

On Feb 23, 2026, Gilead Sciences announced a cash deal to acquire biotech Arcellx for up to $7.8 billion, aiming to broaden its oncology portfolio. Merck & Co. is reportedly preparing to split its pharmaceutical division into separate cancer and non‑cancer units ahead...

Generate Biomedicines Inc., a Massachusetts‑based biotech firm using AI for drug development, announced plans to raise up to $425 million by selling 25 million shares at $15‑$17 each. The filing with the SEC was made on Monday, positioning the company at a...

Aston Martin’s billionaire owner Lawrence Stroll has arranged a deal with his Formula One team to inject capital into the debt‑laden British automaker. The move aims to provide financial support and stabilize the luxury‑car maker’s operations. Deal terms and value...